Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | University of Oxford |
| Country | United Kingdom |
| Start Date | Apr 01, 2021 |
| End Date | Mar 31, 2026 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 221761 |
Meiotic recombination is essential for creation of haploid gametes. Errors in this process cause miscarriage, infertility, and developmental disorders.
Recombination proceeds via repair of programmed DNA breaks; however, the molecular mechanisms ensuring their repair are not well understood.
My work reveals that these breaks are a significant mutagenic force, leading to de novo mutations (DNMs) in 1 in 3 sperm and 1 in 13 eggs.
My proposed research will harness cutting-edge experiments in genetically-engineered mouse models to generate novel data and will further leverage existing population-scale human genetic and phenotypic data.
I will integrate these data through sophisticated statistical analyses to answer the following questions: - What are the properties, causes and impacts of recombination-associated mutations on human health? I will characterize these mutations comprehensively in humans and infer their molecular causes.
I will investigate their impact on common and rare diseases. - What is the mechanism of break repair in recombination?
I will build on my recent work and interrogate meiotic break repair through specialised experimental assays on key proteins in genetically-engineered mice. - What is the mechanism of mutagenesis?
I will characterize the impact of pathways that are identified above as causal by disrupting them in genetically-engineered mice.
University of Oxford
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant